Clinical Trial Update: Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation [Phase 2]

View source ↗

Summary

Late Phase 2 study of DU-176b in non-valvular atrial fibrillation completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26